A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...

China's EAST reactor has made a significant breakthrough in nuclear fusion, sustaining plasmafor 1,066 seconds. The ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

CSL has reported a 7% net profit rise for the December half, with its blood-derived products offsetting weak flu vaccination ...